Thermo Fisher Scientific
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.
Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.
Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
Stock Symbol: TMO
1632 articles about Thermo Fisher Scientific
-
Thermo Fisher Scientific Announces New Cryo-TEM with Expansive Automation Features to Help Accelerate Drug Discovery Research
10/5/2022
Thermo Fisher Scientific Announces New Cryo-TEM with Expansive Automation Features to Help Accelerate Drug Discovery Research.
-
Thermo Fisher Scientific Adds New Ultra-Low Temperature Chest Freezer to Green Portfolio, Offering Eco-Friendly, Compliant, and Secure Cold Storage
10/4/2022
Thermo Fisher Scientific announced the addition of a new freezer to its ultra-low temperature green portfolio, the Thermo Scientific TDE Series -80°C Chest Freezer.
-
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022
10/4/2022
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter 2022 before the market opens on Wednesday, October 26, 2022, and will hold a conference call on the same day at 8:30 a.m. EDT.
-
The gene sequencing industry has really taken off in recent years. Here's a look at the top five genome sequencing companies, ranked by revenue.
-
Thermo Fisher Scientific Launches a More Sustainable Solution for Large-Scale Cell Culture Harvesting
9/28/2022
Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system at the BioProcess International annual conference in Boston, MA.
-
Thermo Fisher Scientific Announces FDA Approval of Oncomine Dx Target Test as the First NGS-Based Companion Diagnostic to Aid in Therapy Selection for Patients with RET Mutations/Fusions in Thyroid Cancers
9/27/2022
The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET -fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC).
-
Thermo Fisher Scientific Partners with Pennsylvania Biotechnology Center to Support Life Sciences Growth in Philadelphia
9/21/2022
The Pennsylvania Biotechnology Center (PABC) announced that Thermo Fisher Scientific has become a founding sponsor supporting the PABC campus in Doylestown, Pa., and their new B+Labs incubator in Philadelphia.
-
Thermo Fisher Scientific’s PPD Clinical Research Business Selected to Support National Cancer Institute’s Cancer Trials Support Unit
9/15/2022
Thermo Fisher Scientific’s PPD Clinical Research Business Selected to Support National Cancer Institute’s Cancer Trials Support Unit.
-
Thermo Fisher Scientific Collaborates with Taiwan Precision Medicine Initiative to Genotype 1 Million People in Taiwan
9/13/2022
Thermo Fisher Scientific partners with the Taiwan Precision Medicine Initiative (TPMI) to advance the next phase of the large-scale predictive genomics study and support its goal of genotyping 1 million people in Taiwan.
-
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
9/7/2022
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Morgan Stanley 2022 Global Healthcare Conference on Monday, September 12, 2022, at 9:55 a.m. (EDT).
-
Thermo Fisher Scientific Showcases Latest Innovations to Improve Biopharmaceutical and Proteomics Workflows
8/29/2022
Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing a new mass spectrometry instrument and consumables that enable biopharmaceutical and proteomics customers to drive scientific breakthroughs and solve analytical challenges.
-
Sonoma Bio announced its plans to erect an 83,000-square-foot operations facility in Seattle, while Thermo Fisher opened a new viral vector manufacturing plant in Massachusetts.
-
Thermo Fisher Scientific to Sponsor Nation's Premier Middle School STEM Competition
8/25/2022
Society for Science (the Society) and Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Thermo Fisher will be the new title sponsor of the Society's middle school STEM (science, technology, engineering and math) competition, the nation's premier STEM competition.
-
New Line of Electrochemistry Bench Meters Simplify pH, Conductivity and Dissolved Oxygen Measurement
8/24/2022
Academic and industry laboratories now have access to a new line of electrochemistry bench meters from Thermo Fisher Scientific that have been designed to easily record accurate measurements of pH, conductivity and dissolved oxygen.
-
Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities
8/24/2022
Thermo Fisher Scientific, the world leader in serving science, expanded its cell and gene therapy capabilities with the opening of its new previously announced viral vector manufacturing facility in Plainville, Mass.
-
Thermo Fisher Scientific’s Largest Single-Use Technology Manufacturing Site Opens in Greater Nashville
8/22/2022
Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville.
-
The FDA is busy accepting drug applications, granting specialty designations and approving drugs for market. Here's a look at this week's FDA activity.
-
FDA Clears ImmunoCAP™ Blood Tests for Wheat and Sesame Allergy
8/17/2022
Today, Thermo Fisher Scientific announces the clearance of ImmunoCAP Specific IgE (sIgE) Allergen Components for wheat and sesame* allergies by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use.
-
FDA Approves First NGS-Based Companion Diagnostic to Aid in Selecting Non-Small Cell Lung Cancer Patients with HER2 (ERBB2) Activating Mutations (SNVs & Exon 20 Insertions) for Treatment with ENHERTU
8/12/2022
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in non-small cell lung cancer (NSCLC).
-
Thermo Fisher Scientific Launches Enhanced Applied Biosystems HIV-1 Genotyping Kit
8/8/2022
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems HIV-1 Genotyping Kit with Integrase, a research use only assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretrovial therapeutics.